SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-021880
Filing Date
2024-05-30
Accepted
2024-05-30 09:15:13
Documents
16
Period of Report
2024-05-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47757
2 OCEAN BIOMEDICAL, INC. ANNOUNCES RECEIPT OF NOTICE FROM NASDAQ REGARDING LATE FI ex99-1.htm EX-99.1 11642
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6832
  Complete submission text file 0001493152-24-021880.txt   293933

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ocea-20240522.xsd EX-101.SCH 3509
5 XBRL DEFINITION FILE ocea-20240522_def.xml EX-101.DEF 26524
6 XBRL LABEL FILE ocea-20240522_lab.xml EX-101.LAB 36962
7 XBRL PRESENTATION FILE ocea-20240522_pre.xml EX-101.PRE 25148
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5601
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 241001284
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)